A prospective trial of bupropion sr augmentation of partial and non-responders to serotonergic antidepressants / Charles DeBattista en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 1 (Febrero) . - pp. 27-30 Título : A prospective trial of bupropion sr augmentation of partial and non-responders to serotonergic antidepressants Tipo de documento: texto impreso Autores: Charles DeBattista, Autor ; H. Brent Solvason, Autor ; Jennifer Poirier, Autor Fecha de publicación: 2023 Artículo en la página: pp. 27-30 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos de segunda generación, Bupropión, Trastorno depresivo, Resistencia al medicamento, Inhibidores selectivos de la recaptación de serotonina. Resumen: Many patients fail to achieve an adequate response to a given antidepressant trial. The best-studied augmentation agents, lithium and thyroid supplementation are less commonly used. Augmenting antidepressants with bupropion has become an increasingly common strategy in the treatment of resistant depression. Several case reports and 2 open label studies suggest efficacy of this strategy. Link: ./index.php?lvl=notice_display&id=31041 [artículo] A prospective trial of bupropion sr augmentation of partial and non-responders to serotonergic antidepressants [texto impreso] / Charles DeBattista, Autor ; H. Brent Solvason, Autor ; Jennifer Poirier, Autor . - 2023 . - pp. 27-30. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 1 (Febrero) . - pp. 27-30 Palabras clave: Antidepresivos de segunda generación, Bupropión, Trastorno depresivo, Resistencia al medicamento, Inhibidores selectivos de la recaptación de serotonina. Resumen: Many patients fail to achieve an adequate response to a given antidepressant trial. The best-studied augmentation agents, lithium and thyroid supplementation are less commonly used. Augmenting antidepressants with bupropion has become an increasingly common strategy in the treatment of resistant depression. Several case reports and 2 open label studies suggest efficacy of this strategy. Link: ./index.php?lvl=notice_display&id=31041

---

1 (1 - 1 / 1)